NCT01301001View on ClinicalTrials.gov

A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response

NACompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Vulvodynia
Interventions
DRUG

Placebo oral capsule

Placebo 2 capsules am and 3 capsules pm

DRUG

Gabapentin

Gabapentin 1200 mg am and 1800 mg pm

Trial Locations (3)

38104

Clinical Research Center, Memphis

08901-1962

Rutgers - Robert Wood Johnson Medical School, New Brunswick

14642-0002

University of Rochester School of Medicine and Dentistry, Rochester

All Listed Sponsors
lead

University of Tennessee

OTHER

NCT01301001 - A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response | Biotech Hunter | Biotech Hunter